CSPC Pharmaceutical Group Ltd. (1093) Stock Recommendation | Score, Valuation, Technicals & Financial Trend

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Comparison

Company

Score

Quality

Valuation

Financial

Technical

Wuxi Biologics (Cayman), Inc.

3SBio, Inc.

Alphamab Oncology

CSPC Pharmaceutical Group Ltd.

Sirnaomics Ltd.

Zai Lab Ltd.

AIM Vaccine Co., Ltd.

Ascentage Pharma Group International Co., Ltd.

Laekna, Inc.

Beijing Lüzhu Biotechnology Co., Ltd.

Genscript Biotech Corp.

Why is CSPC Pharmaceutical Group Ltd. ?

Flat results in Dec 25

OPERATING CASH FLOW(Y) Lowest at HKD 11,826.76 MM
RAW MATERIAL COST(Y) Grown by 7.98% (YoY)
OPERATING PROFIT(Q) Lowest at HKD 2,324.49 MM

With ROE of 5.80%, it has a Very Expensive valuation with a 2.87 Price to Book Value

Over the past year, while the stock has generated a return of 18.67%, its profits have risen by 25.8% ; the PEG ratio of the company is 2.2

Real-Time Research Report

Verdict Report

How much should you sell?

All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is CSPC Pharmaceutical Group Ltd. for you?

High Risk, Medium Return

Absolute

Risk Adjusted

Volatility

CSPC Pharmaceutical Group Ltd.

18.67%

0.18

53.72%

Hang Seng Hong Kong

8.76%

0.45

19.63%

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

11.96%

EBIT Growth (5y)

19.40%

EBIT to Interest (avg)

29.07

Debt to EBITDA (avg)

2.63

Net Debt to Equity (avg)

-0.24

Sales to Capital Employed (avg)

0.36

Tax Ratio

19.81%

Dividend Payout Ratio

78.68%

Pledged Shares

Institutional Holding

0.00%

ROCE (avg)

18.91%

ROE (avg)

14.36%

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

Industry P/E

Price to Book Value

2.87

EV to EBIT

34.49

EV to EBITDA

28.55

EV to Capital Employed

3.60

EV to Sales

7.61

PEG Ratio

2.16

Dividend Yield

0.02%

ROCE (Latest)

10.43%

ROE (Latest)

5.80%

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Bearish

Mildly Bearish

RSI

No Signal

Bollinger Bands

Bearish

Mildly Bullish

Moving Averages

Bearish (Daily)

KST

Bearish

Bullish

Dow Theory

Mildly Bearish

OBV

Mildly Bearish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

2What is working for the Company

DIVIDEND PAYOUT RATIO(Y)

Highest at 117.65%

DIVIDEND PER SHARE(HY)

Highest at HKD 2.65

-7What is not working for the Company

OPERATING CASH FLOW(Y)

Lowest at HKD 11,826.76 MM

RAW MATERIAL COST(Y)

Grown by 7.98% (YoY

OPERATING PROFIT(Q)

Lowest at HKD 2,324.49 MM

OPERATING PROFIT MARGIN(Q)

Lowest at 16.68 %

PRE-TAX PROFIT(Q)

Lowest at HKD 1,725.55 MM

NET PROFIT(Q)

Lowest at HKD 1,329.97 MM

Here's what is working for CSPC Pharmaceutical Group Ltd.

Dividend per share

Highest at HKD 2.65

in the last five years

MOJO Watch

Company is distributing higher dividend from profits generated

DPS (HKD)

Dividend Payout Ratio

Highest at 117.65%

in the last five years

MOJO Watch

Company is distributing higher proportion of profits generated as dividend

DPR (%)

Depreciation

Highest at HKD 787.79 MM

in the last five periods

MOJO Watch

The expenditure on assets done by the company may have gone into operation

Depreciation (HKD MM)

Depreciation

At HKD 787.79 MM has Grown at 6.32%

period on period (QoQ)

MOJO Watch

The expenditure on assets done by the company has gone into productive use which should positively reflect in the future sales

Depreciation (HKD MM)

Here's what is not working for CSPC Pharmaceutical Group Ltd.

Operating Cash Flow

Lowest at HKD 11,826.76 MM

in the last three years

MOJO Watch

The company's cash revenues from business operations are falling

Operating Cash Flows (HKD MM)

Operating Profit

Lowest at HKD 2,324.49 MM

in the last five periods

MOJO Watch

Near term Operating Profit trend is negative

Operating Profit (HKD MM)

Operating Profit Margin

Lowest at 16.68 %

in the last five periods

MOJO Watch

Company's profit margin has deteriorated

Operating Profit to Sales

Pre-Tax Profit

Lowest at HKD 1,725.55 MM

in the last five periods

MOJO Watch

Near term Pre-Tax Profit trend is negative

Pre-Tax Profit (HKD MM)

Net Profit

Lowest at HKD 1,329.97 MM

in the last five periods

MOJO Watch

Near term Net Profit trend is negative

Net Profit (HKD MM)

Raw Material Cost

Grown by 7.98% (YoY)

MOJO Watch

The company's ability to pass on the cost of raw materials to customers has deteriorated; this may lead to a fall in profit margin

Raw Material Cost as a percentage of Sales